View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Clinical Trial Search block Test

Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents >= 6 to < 18 years of age

Phase: III
Clinicaltrials.gov ID: NCT04743141

Rimegepant 312

What is the goal of the study?

To evaluate the safety and tolerability of rimegepant in children and adolescents (age >= 6 to < 18 years of age).

Everyone